GEHCGE HealthCare
Price
-11%1YEnd-of-day closes, not the intraday tick.
Mostly good, one thing to check: growth
Quality mixed, no red flags, undemanding price, growth fading, the market undecided.
GE HealthCare Technologies Inc. (“GE HealthCare,” the “Company,” “our,” “us,” or “we”) is a leading global healthcare solutions provider of advanced medical technology, pharmaceutical diagnostics, and AI, cloud and software solutions that help clinicians tackle the world’s most complex diseases. We have approximately 54,000 colleagues dedicated to our purpose to create a world where healthcare has no limits. Serving patients and providers for nearly 130 years, GE HealthCare is delivering bold innovations designed for the next era of medicine to help clinicians deliver more personalized, precise patient care.
In the company’s own words · 10-K filed Feb 4, 2026 · SEC EDGAR
Charts
As reported to the SEC, without any scoring.
GE HealthCare (GEHC) reported revenue of $5.13B in Q1 2026 (quarter ended Mar 31, 2026), up 7.4% from the same quarter a year earlier. That came with a gross margin of 39% and net income of $389M (7.6% of revenue). For the full year FY2025, revenue was $20.6B (+4.8% year on year) and net income $2.08B. Its largest segment in Jun 2026 was AIS at $2.39B, 64% of the disclosed total, well ahead of P Dx at 23%. The next results filing is expected around Oct 28, 2026, the same week as a year ago.
What the company said
The company's own words from its current reports to the SEC, newest first
- Sep 22, 2026On September 22, 2026, the Board of Directors (the “Board”) of GE HealthCare Technologies Inc. (the “Company”) appointed Pascal Desroches to serve as a director of the Company, effective January 4, 2027.Director or officer change · Form 8-K
- Aug 18, 2026On August 13, 2026, the Board of Directors (the “Board”) of GE HealthCare Technologies Inc. (“GE HealthCare”) appointed William K. Grogan as Chief Financial Officer, effective September 14, 2026.Director or officer change · Form 8-K
- Jul 29, 2026Recast Unaudited Historical Financial Information Reflecting the Company’s New Reportable Segment Structure.Regulation FD disclosure · press release
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
Business segments
Jun 2026 · $3.73BThe company’s own SEC segment disclosure.
- AIS$2.39B64%
- P Dx$843.0M23%
- PCS$503.0M13%
Why these answers
Each answer with the checks it was read from. Open one for the numbers.
Conflicts between checks are named, never averaged, and thin data says so.
Medical Devices
The closest names by size in the same industry